Quality of life in patients with primary and metastatic brain cancer as reported in the literature using the EORTC QLQ-BN20 and QLQ-C30

被引：1

作者：

Chiu, Leonard ^{[1
]}

Chiu, Nicholas ^{[1
]}

Zeng, Liang ^{[1
]}

Zhang, Liying ^{[1
]}

Popovic, Marko ^{[1
]}

Chow, Ronald ^{[1
]}

Lam, Henry ^{[2
]}

Poon, Michael ^{[1
]}

Chow, Edward ^{[1
]}

机构：

[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Rapid Response Radiotherapy Program, Dept Radiat Oncol,Odette Canc Ctr, Toronto, ON M4N 3M5, Canada

[2] Sunnybrook Hlth Sci Ctr, Lib Serv, Toronto, ON M4N 3M5, Canada

来源：

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH | 2012年 / 12卷 / 06期

关键词：

brain metastases; brain tumors; QLQ-BN20; QLQ-C30; quality of life; GLIOBLASTOMA; VALIDATION; RADIOTHERAPY;

D O I：

10.1586/ERP.12.70

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The objective of this study is to compare the differences in quality of life (QoL) as assessed by the QLQ-BN20 and QLQ-C30 in patients with primary and metastatic brain neoplasms. A systematic literature search was conducted over the OvidSP platform in MEDLINE (1980-2012) and EMBASE (1980-2012). Studies in which the QLQ-BN20 was used as a QoL assessment for patients with malignant brain tumors (either metastatic or primary) were included in the study. Articles were included if they reported scores of at least one subscale of the QLQ-C30 or QLQ-BN20. The weighted means of the QLQ-BN20 and QLQ-C30 subscales were calculated based on sample size for included studies. Weighted analysis of variance was conducted to compare these scores in primary and metastatic brain patients. A p-value of < 0.05 was considered statistically significant. A total of 14 studies (16 arms: three brain metastases and 13 primary brain tumors) were identified and included in the data analysis. Fifteen of the 16 arms included QLQ-C30 scores along with QLQ-BN20 scores. Performance status of patients in both cohorts was similar. Patients with primary brain tumors and brain metastases had the following findings: physical functioning (weighted mean: 79.18 vs 74.93), global QoL (61.88 vs 59.44), role functioning (67.37 vs 75.00) and emotional functioning (70.44 vs 71.86); but none of them were statistically significantly different. Only cognitive functioning from the QLQ-C30 was significantly worse in patients with primary brain tumors (p-value = 0.0199). Despite cognitive function being significantly worse in patients with primary brain tumors, patients with metastatic brain tumors and patients with primary brain tumors have very similar QoL profiles. The study is limited by the large discrepancy in cohort sizes (1260 patients with primary brain cancer vs 183 patients with brain metastases) and the lack of clinical data.

引用

页码：831 / 837

页数：7

共 21 条

[11] Radiotherapy for glioblastoma in the elderly [J].

Keime-Guibert, Florence ;

Chinot, Olivier ;

Taillandier, Luc ;

Cartalat-Carel, Stephanie ;

Frenay, Marc ;

Kantor, Guy ;

Guillamo, Jean-Sebastien ;

Jadaud, Eric ;

Colin, Philippe ;

Bondiau, Pierre-Yves ;

Menei, Philippe ;

Loiseau, Hugues ;

Bernier, Valerie ;

Honnorat, Jerome ;

Barrie, Maryline ;

Mokhtari, Karima ;

Mazeron, Jean-Jacques ;

Bissery, Anne ;

Delattre, Jean-Yves ;

Lacomblez, L. ;

Levy-Soussan, M. ;

Mallet, A. ;

Houssard, C. ;

Delgadillo, D. ;

Poitou, M. ;

Hoang-Xuan, K. ;

Sanson, M. ;

Carpentier, A. F. ;

Laigle-Donadey, F. ;

Taillibert, S. ;

Cornu, P. ;

Omuro, A. ;

Capelle, L. ;

Boch, A. -L. ;

Duffau, H. ;

Simon, J. -M. ;

Medioni, J. ;

Broet, P. ;

Schmitt, A. ;

Garat, E. ;

Mathieu, P. ;

Camille, N. ;

Collin, J. -P. ;

Bailet, B. ;

Ciais, C. ;

Fauchon, F. ;

Lebrun, C. ;

Guesdan, G. ;

Stadelmaier, N. ;

Lombard, I. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1527-1535

[12] Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran [J].

Khoshnevisan, Alireza ;

Yekaninejad, Mir Saeed ;

Ardakani, Shahab Kamali ;

Pakpour, Amir H. ;

Mardani, Azam ;

Aaronson, Neil K. .

HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10

[13] Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients [J].

Klein, M ;

Taphoorn, MJB ;

Heimans, JJ ;

van der Ploeg, HM ;

Vandertop, WP ;

Smit, EF ;

Leenstra, S ;

Tulleken, CAF ;

Boogerd, W ;

Belderbos, JSA ;

Cleijne, W ;

Aaronson, NK .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (20) :4037-4047

[14]

Leung A, 2011, EXPERT REV PHARM OUT, V11, P693, DOI [10.1586/ERP.11.66, 10.1586/erp.11.66]

[15] Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients [J].

Maringwa, J. ;

Quinten, C. ;

King, M. ;

Ringash, J. ;

Osoba, D. ;

Coens, C. ;

Martinelli, F. ;

Reeve, B. B. ;

Gotay, C. ;

Greimel, E. ;

Flechtner, H. ;

Cleeland, C. S. ;

Schmucker-Von Koch, J. ;

Weis, J. ;

Van Den Bent, M. J. ;

Stupp, R. ;

Taphoorn, M. J. ;

Bottomley, A. .

ANNALS OF ONCOLOGY, 2011, 22 (09) :2107-2112

[16] The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires [J].

Osoba, D ;

Aaronson, NK ;

Muller, M ;

Sneeuw, K ;

Hsu, MA ;

Yung, WKA ;

Brada, M ;

Newlands, E .

QUALITY OF LIFE RESEARCH, 1996, 5 (01) :139-150

[17] Effects of Radiotherapy for Brain Metastases on Quality of Life (QoL) [J].

Steinmann, Diana ;

Schaefer, Christof ;

van Oorschot, Birgitt ;

Wypior, Hans-Joachim ;

Bruns, Frank ;

Boelling, Tobias ;

Sehlen, Susanne ;

Hagg, Juliane ;

Bayerl, Anja ;

Geinitz, Hans ;

Hipp, Matthias ;

Vordermark, Dirk .

STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (03) :190-197

[18] An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients [J].

Taphoorn, Martin J. B. ;

Claassens, Lily ;

Aaronson, Neil K. ;

Coens, Corneel ;

Mauer, Murielle ;

Osoba, David ;

Stupp, Roger ;

Mirimanoff, Rene O. ;

van den Bent, Martin J. ;

Bottomley, Andrew .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (06) :1033-1040

[19] Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life [J].

Weber, Damien C. ;

Caparrotti, Francesca ;

Laouiti, Mohamed ;

Malek, Karim .

RADIATION ONCOLOGY, 2011, 6

[20] Acute effect of palonosetron on electrocardiographic parameters in cancer patients: a prospective study [J].

Yavas, C. ;

Dogan, U. ;

Yavas, G. ;

Araz, M. ;

Ata, O. Yavas .

SUPPORTIVE CARE IN CANCER, 2012, 20 (10) :2343-2347

← 1 2 3 →